English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51716780    線上人數 :  728
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lu li chun"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 26-35 / 38 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立臺灣大學 2015 Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials Shao, Yu-Yun; Shau, Wen-Yi; Chan, Soa-Yu; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿
國立臺灣大學 2014 beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma Lu, Li-Chun; Shao, Yu-Yun; Lee, Yi-Hsuan; Hsieh, Min-Shu; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒
國立臺灣大學 2014 Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy Shao, Yu-Yun; Wu, Chih-Horng; Lu, Li-Chun; Chan, Soa-Yu; Ma, Yu-Yi; Yen, Feng-Chu; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 吳志宏; 鄭安理; 徐志宏; 呂理駿
國立臺灣大學 2014 Clinical Characteristics of Advanced Hepatocellular Carcinoma Patients with Prolonged Survival in the Era of Anti-angiogenic Targeted-therapy Lu, Li-Chun; Shao, Yu-Yun; Chan, Soa-Yu; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿
國立臺灣大學 2014 Recent Advances in the Prevention of Hepatocellular Carcinoma Recurrence Lu, Li-Chun; Cheng, Ann-Lii; Poon, Ronnie T. P.; 鄭安理; 呂理駿
國立臺灣大學 2014 Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理; 徐志宏; 呂理駿
國立臺灣大學 2013 Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma Lu, Li-Chun; Shao, Yu-Yun; Kuo, Raymond N. C.; Lin, Zhong-Zhe; Yeh, Yi-Chun; Shau, Wen-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 郭年真; 呂理駿
國立臺灣大學 2013 WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 鄭安理; 徐志宏; 呂理駿
國立臺灣大學 2013 Unique histopathologic features of brain metastases from hepatocellular carcinoma Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書
國立臺灣大學 2012 Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Hsu, Chun; Cheng, Wen-Fang; Lin, Yu-Lin; Cheng, Ann-Lii; Yeh, Kun-Huei; 鄭文芳; 邵幼雲; 林育麟; 鄭安理; 徐志宏; 許駿; 葉坤輝; 呂理駿

顯示項目 26-35 / 38 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目